Association of Epidural Labor Analgesia With Offspring Risk of Autism Spectrum Disorders.
Elizabeth Wall-Wieler, Brian T Bateman, Ana Hanlon-Dearman...
https://pubmed.ncbi.nlm.nih.gov/33871547/Actively Recruiting
Led by Dong-Xin Wang · Updated on 2026-06-09
4645
Participants Needed
2
Research Sites
104 weeks
Total Duration
This research aims to explore how maternal neuraxial labor analgesia exposure during labor may affect the long-term neurodevelopment of children. The study focuses on primiparous women aged 18 to 35 with term single cephalic pregnancies who are preparing for vaginal delivery. Researchers are examining whether the use of neuraxial labor analgesia is associated with risks or benefits for neurodevelopmental delay in offspring at 24 months of age. Participants will be grouped based on whether they receive neuraxial labor analgesia, which includes epidural analgesia or combined spinal-epidural analgesia, administered according to routine practices at each study center. Mothers who do not accept neuraxial labor analgesia will receive analgesics prescribed by obstetricians as per routine care. The study collects data prospectively and follows the childrens neurodevelopment over time. During the study, participants will be monitored through regular prenatal examinations and followed up to assess the prevalence of neurodevelopmental delay in offspring at 6, 12, and 24 months of age. Maternal depressive symptoms will also be evaluated at several points after childbirth. Researchers will observe outcomes related to offspring neurodevelopment and maternal mental health while considering risks associated with analgesia use. The total study period extends until 2028, with primary outcome assessment at 24 months of age for the offspring.
CONDITIONS
Neuraxial Labor Analgesia and Offspring Neurodevelopment
D
Dong-Xin Wang, MD,PHD
T
Ting Ding, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Dong-Xin Wang
Lead Sponsor
Shenzhen Maternity & Child Healthcare Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 24 months after childbirth
Participants are observed based on whether they receive neuraxial labor analgesia or other analgesics during labor according to routine practices at each study center. Data on maternal and offspring outcomes are collected over time.
Regular assessments at 6, 12, and 24 months for offspring neurodevelopment and maternal depressive symptoms
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elizabeth Wall-Wieler, Brian T Bateman, Ana Hanlon-Dearman...
https://pubmed.ncbi.nlm.nih.gov/33871547/Randall P Flick, Kunmoo Lee, Ryan E Hofer...
https://pubmed.ncbi.nlm.nih.gov/20736436/Mei Wei, Xiaoyan Bian, Jane Squires...
https://pubmed.ncbi.nlm.nih.gov/26887546/Zhi-Hua Liu, Shu-Ting He, Chun-Mei Deng...
https://pubmed.ncbi.nlm.nih.gov/31356375/Cynthia A Wong
https://pubmed.ncbi.nlm.nih.gov/21072284/Sarah Morton, Justin Kua, Christopher J Mullington
https://pubmed.ncbi.nlm.nih.gov/33218673/Dong-Xin Wang
Lead Sponsor
Shenzhen Maternity & Child Healthcare Hospital
Collaborating Sponsor